PCSK9 and acute coronary syndrome: Furthermore, their study demonstrated the association between elevated PCSK9 level and a higher incidence of atherothrombotic events, suggesting that PCSK9 can be used as a biomarker of clinical ischemic incidents and higher platelet activation, independently of other factors in acute coronary syndrome patients [70].